Atlas Trials

Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer

Clinical trial NCT03244358 · TERMINATED

Trial details

NCT number
NCT03244358
Sponsor
Sun Yat-sen University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Triple Negative Breast Cancer
Start date
2017-03-01
Primary completion
2020-12-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.